Span Diagnostic shares closed at 33.04 on February 19, 2025 (BSE) and has given 56.96% returns over the last 6 months. Span Diagnostic Consolidated Quarterly Results in Rs. Cr. Dec’24 Sep’24 Dec’23 Net Sales/Income from operations 1.90 0.43 3.01 EBITDA stands at Rs. 0.21 crore in December 2024 down 72.73% from Rs.0.77 crore in 2023. Net Loss at 0.15 crore in January 2024 down 335.03% from 0.06 crore in Dec’2023. Pledged/Encumbered – Number of shares (Crores) — — — – Per. of Shares (as a % of the total sh. of Promoters and Promoter Group Shareholding) (crores) Equity Dividend Rate (P/L) — — — — per. share (as % of total Share Cap. of the company) ( crores) P/L Before Other Inc., Int., Excpt. Items & Tax -0.18 0.25 0.24 Tax 0.04 0.01 0.18 P/ L After M.I.I & Associates -0,15 0.4 0.46 5.46 Reserves Excluding Revaluation Reserves — –. — Equity D dividend rate (p/l) — – 0.44 0.12 EPS After Extra Ordinary Basic EPS -0., 0.39 0. 44 0. 12 Diluted EPS – 0,390.440.12 Share Holding No Of Shares (Crore) —- — — Share Holding (%) — – — — Promoters & Promoter group Shareholding (crore)
